New England Journal of Medicine

Article

New England Journal of Medicine is a recurring publication in the Astral Codex Ten archive, appearing 3 times across 3 issues between July 04, 2021 and August 14, 2025. The archive places it in contexts such as “anti-screening New England Journal of Medicine article”; “the prestigious New England Journal of Medicine published an article in October saying maybe this might be true”; “C. H. van Dyck et al., New England Journal of Medicine, vol. 388, no. 1”. It most often appears alongside Nature, A. Bejanin, A. de Calignon.

Metadata

  • Category: Publications
  • Mention count: 3
  • Issue count: 3
  • First seen: July 04, 2021
  • Last seen: August 14, 2025

Appears In

Source Context

Recovered passages from the original issue text. When the raw archive preserved outbound links inside the source passage, they are listed directly under the quote.

July 04, 2021 · Original source
2: Comment of the week is Gene Smith on polygenic screening, especially the attempt to calculate cost-effectiveness. "My overall conclusion is that if we somehow end up banning pre-implantation genetic testing it will be one of the worst decisions we have ever made. The impact would be on-par with a worldwide ban on vaccines or sewage systems. It would likely cost the average person around 5 years of healthy life." And many people brought up this anti-screening New England Journal of Medicine article that came out the same day as my post, although I can't find a good unpaywalled link.
November 25, 2021 · Original source
32: Last spring Robin Hanson and others mooted the idea that viral load affected disease severity; eg if you inhaled one coronavirus particle, you’d get a mild coronvirus case, but if you inhaled 100,000, you’d get a severe case. I hadn’t realized that the prestigious New England Journal of Medicine published an article in October saying maybe this might be true (though not providing any new evidence). This sparked responses by other people saying maybe it might be false (also not providing evidence) - honestly the whole thing was weirdly centered around PR (“if we say this is true, it might make people like masks more!”, “but if we say it’s false, that could make people like vaccines more!”). The only useful thing I got out of this is that Stephan Guyenet looked into a pathogen load/severity correlation for diarrhea and found there was none.
August 14, 2025 · Original source
[80] C. H. van Dyck et al., “Lecanemab in early Alzheimer’s disease,” New England Journal of Medicine, vol. 388, no. 1, pp. 9–21, 2023, doi: 10.1056/NEJMoa2212948.
[81] M. A. Mintun et al., “Donanemab in Early Alzheimer’s Disease,” New England Journal of Medicine, vol. 384, no. 18, pp. 1691–1704, May 2021, doi: 10.1056/NEJMoa2100708.
[83] S. Salloway et al., “Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer’s disease,” New England Journal of Medicine, vol. 370, no. 4, pp. 322–333, 2014, doi: 10.1056/NEJMoa1304839.